Introduction
Neural tube defects (NTDs) are among the most common structural birth defects in humans affecting anywhere from 1 in 100 to 6 in 10,000 live births (Li et al., 2006; Parker et al., 2010; Zohn, 2012 Zohn, , 2014 Liu et al., 2016) . NTDs such as anencephaly and spina bifida occur when neural tube closure fails in the anterior and posterior ends of the neural tube, respectively. The causes of NTDs are complex and involve both genetic and environmental factors (Zohn and Sarkar, 2008; Zohn, 2012 Zohn, , 2014 . Multiple studies implicate periconception maternal nutrition as an important factor influencing the occurrence of NTDs and folic acid has emerged as an important micronutrient (Smithells et al., 1976; Scott et al., 1990; Blom et al., 2006; Czeizel, 2009; Obican et al., 2010) . Furthermore, human and animal studies demonstrate a clear benefit of folic acid supplementation for the prevention of NTDs (Czeizel, 2009; Gray and Ross, 2009; Harris, 2009; Obican et al., 2010) .
To improve folate levels in women of childbearing age, wheat flour is now fortified with folic acid in many countries and is associated with significant reductions in the incidence of NTDs (Eichholzer et al., 2006; Crider et al., 2011; Obican et al., 2010) . However, fortification has only reduced NTD rates to certain levels (Crider et al., 2011) . Similarly, NTDs in many mouse models are not prevented by folic acid supplementation (Gray and Ross, 2009; Harris, 2009 ). Together these observations suggest that not all NTDs can be prevented by folic acid supplementation. Consequently, NTDs still represent a significant proportion of birth defects and there is a pressing need for additional strategies for prevention.
Other nutrients have emerged from retrospective studies as potential factors to influence the incidence of NTDs (Scott et al., 1990; Czeizel, 2009; Czeizel and Banhidy, 2011; Kappen, 2013) . Iron deficiency is one of the most common micronutrient deficiencies in women of childbearing age (Lopez et al., 2016) . Iron and folate deficiencies often occur simultaneously and iron and folate metabolism are linked in many ways (Herbig and Stover, 2002) . However, unlike the wealth of data supporting the importance of folate in prevention of NTDs, only a handful of studies directly investigated the impact of iron and with mixed results (Weekes et al., 1992; Groenen et al., 2004; Felkner et al., 2005; Molloy et al., 2014) . Mouse models with disruption of iron homeostasis have not provided clarity due to early embryonic lethality or redundancy (De Domenico et al., 2008) .
Our previous studies suggested iron might be required for neural tube closure (Zohn et al., 2007; Mao et al., 2010) . In the N-ethyl-N-nitroso-urea (ENU)-induced flatiron (ffe) mouse line, we identified a hypomorphic mutation in the iron exporter Fpn1 resulting in NTDs. During neurulation, Fpn1 is expressed in tissues essential for delivery of nutrients to the embryo (Donovan et al., 2000 (Donovan et al., , 2005 . Conditional deletion studies demonstrate that Fpn1 expression in the visceral endoderm and visceral endoderm-derived lineages of the yolk sac is critical for neural development (Mao et al., 2010) . Multiple transporters are localized to the apical surface of the visceral endoderm to mediate iron uptake from the maternal environment, but Fpn1 is the only transporter on the basal surface responsible for export of iron out of the visceral endoderm to the developing embryo (Donovan et al., 2005) . Thus mutation of Fpn1 is expected to result in iron overload in the visceral endoderm along with iron deficiency in the embryo proper.
The visceral endoderm not only provides nutrients to the embryo, but also functions as a specialized signaling center necessary for induction of the anterior neural tube (Srinivas, 2006; Stower and Srinivas, 2014) . Mutations that affect formation and/or function of the anterior visceral endoderm (AVE) result in a spectrum of phenotypes ranging from mild anterior truncations to headless embryos (Thomas and Beddington, 1996; Acampora et al., 1998; Kimura et al., 2000) . The AVE initially forms at the distal end of the embryo and migrates to the anterior region to overlie the nascent anterior neural plate (Thomas and Beddington, 1996; Rodriguez et al., 2001; Srinivas et al., 2004) . In addition to neural tube closure defects, Fpn1 mutants show forebrain truncations that are also dependent on expression of Fpn1 in the visceral endoderm lineage (Mao et al., 2010) . Because forebrain truncations can be phenocopied by culture of wild-type embryos with iron chelators, iron deficiency is likely responsible for these defects (Mao et al., 2010) .
Migration of the AVE is impaired in Fpn1 ffe/null transheterozygous embryos indicating that iron overload in the visceral endoderm might also have a negative impact on embryonic development (Mao et al., 2010) . While a sizable domain of anterior forebrain is initially induced in Fpn1 mutants, this anterior neural tissue is not maintained and by embryonic day 8.5 the forebrain is severely truncated. Thus, defects in Fpn1 mutants could be due to iron overload in the visceral endoderm, iron deficiency in the embryo proper or a combination of the two. To begin to distinguish between these possibilities, in this study we 
Materials and Methods

MOUSE LINES AND DIET SUPPLEMENTATION
The Fpn1 ffe mouse line was described previously (Zohn et al., 2007) 
MATING EXPERIMENTS AND PHENOTYPIC ANALYSIS
Females were mated with wild-type or Fpn1 ffe/1 males and copulation verified by the presence of a vaginal plug 0.5 days post coitum (dpc). Pregnant females were kept on diets until sacrificed at 9.5 or 11.5 dpc. Upon sacrifice, maternal blood was retrieved by cardiac puncture. Blood was allocated to heparin-coated tubes for analysis of folate levels in whole blood, uncoated Eppendorf tubes for serum separation and analysis of serum ferritin levels or EDTA (Eethylenediaminetetraacetic acid) coated tubes for complete blood counts (CBCs). Embryos were dissected and exencephaly assessed by visual inspection. Yolk sacs were used to genotype embryos as described previously (Zohn et al., 2007; Mao et al., 2010) . A proportion of embryos dissected at 9.5 dpc were subjected to in situ hybridization analysis with a digoxigenin-labeled antisense probe targeting Six3 (Mao et al., 2010) . These embryos were also used to measure the size of the forebrain, crown-rump length, and somite numbers. Embryos dissected at 11.5 dpc were used for analysis of folate levels.
ANALYSIS OF FERRITIN AND FOLATE IN DAMS AND EMBRYOS
Serum ferritin levels were determined by enzyme-linked immunosorbent assay (ELISA) according to manufactures instructions (Abnova Ferritin [Mouse] ELISA Kit #KA1941). Folate levels were determined by the microbiological method using Enterococcus hirae (ATCC 8043) as described (Horne and Patterson, 1988; Molloy and Scott, 1997) . For determination of folate content in embryos, 11.5 dpc embryos were processed as described (Kur et al., 2014) then folate levels determined by the Microbiological assay. Blood samples were sent to Charles River Laboratories, Inc (USA) for CBC analysis.
STATISTICAL METHODS
Statistical analyses were performed using GraphPad Prism software (GraphPad Software Inc., La Jolla, CA). All results are reported as mean 6 SE. The Fisher's exact test was used to determine significance of reductions in NTD frequency. The significance of the effect of diets on nutrient levels and CBC analyses were determined using two-factor analysis of variance (ANOVA) with posthoc analysis by Sidak's multiple comparisons or Tukey tests as indicated.
Significance of changes in forebrain size, embryo weight, and crown rump length were determined by the unpaired t test.
Results
IRON SUPPLEMENTATION REDUCES THE INCIDENCE OF NTD IN FPN1 FFE/ FFE MUTANT EMBRYOS
To determine if iron supplementation could reduce the incidence of NTD in Fpn1 ffe/ffe mutant embryos, Fpn1
females were fed either a standard synthetic control diet or the identical diet supplemented with 0.5% carbonyl iron for 4 weeks beginning at weaning. Supplemented females were mated to Fpn1 ffe/1 males and timed pregnancies recorded. For these studies, a relatively high dosage of supplemental iron (0.5% carbonyl iron) was used. Previous work demonstrated that the Fpn1 ffe mutation results in greatly reduced activity of the Fpn1 iron transporter (Zohn et al., 2007) . Thus, we reasoned a high dosage of iron would be needed to allow for sufficient iron transport on this hypomorphic mutant background.
While Fpn1 ffe/ffe mutants do show both exencephaly and spina bifida (Mao et al., 2010) , spina bifida is difficult to assess at earlier stages of development and only exencephaly was scored in this study. At 9.5 dpc, exencephaly was counted in 13 to 24 somite-staged embryos by visual inspection when the neural folds failed to transform from the convex to midline convergent morphology. In embryos dissected at 11.5 dpc, exencephaly was scored when the brain exhibited the "cauliflower like" morphology typical of exencephaly. As shown in Figure 1 , the frequency of NTDs in embryos from dams fed the control diet was approximately 75% (n 5 48). Supplementation with 0.5% carbonyl iron significantly reduced the incidence of NTDs to 40% (p 5 0.0002). No difference was observed in the frequency of NTDs between embryos analyzed at 9.5 and 11.5 dpc (Supporting Figure S1 , which is available online). These data demonstrate that NTDs in Fpn1 ffe mutants can be prevented by periconceptional iron supplementation.
At 9.5 dpc, crown-rump measurements indicate that Fpn1 ffe mutant embryos were smaller than wild-type littermates on both the control (p 5 0.06) and high iron (p 0.01) diets (Fig. 2A) . While smaller, mutant embryos dissected at 9.5 dpc were not developmentally delayed compared with wild-type littermates as indicated by somite numbers (Fig. 2B) . Similarly, developmental stage was essentially the same in embryos dissected at 9.5 dpc from dams fed the control versus high iron diets (Fig. 2B) . Weights of wild-type versus mutant embryos dissected at 11.5 dpc from dams fed either control or high folic acid diets were similar (p > 0.05). However, weights of mutant and wild-type embryos from dams fed the high iron diet were smaller than embryos from dams fed the control diets (p 0.005; Fig. 2C ).
NTDS IN THE FPN1 FFE/FFE LINE ARE NOT PREVENTED BY FOLATE SUPPLEMENTATION
To determine if folic acid supplementation can prevent NTDs in the Fpn1 ffe model, heterozygous females were a fed diet containing 10 or 2 ppm folic acid (high folic acid and control diets, respectively) for 4 weeks before mating. This protocol prevents NTDs in some mouse lines (Carter et al., 1999; Marean et al., 2011) , but in others has a negative impact on embryonic development (Marean et al., 2011) . While no obvious adverse effects on development were observed on the Fpn1 ffe background, folic acid supplementation did not reduce the frequency of NTDs in Fpn1 ffe/ffe mutants ( Fig. 1B ; 82 vs. 75% p > 0.05). To determine if dual supplementation with folic acid and iron could further reduce the incidence of NTDs, Fpn1 ffe/1 females were supplemented with a diet that contains both 10 ppm folic acid and 0.5% carbonyl iron. Dual supplementation did not reduce the frequency of NTDs beyond the reduction seen with iron supplementation alone (31 vs. 40%; p > 0.05). These results demonstrate that NTDs in the Fpn1 ffe/ffe mutant line are not prevented by folate supplementation.
Folate supplementation alone had no effect on the size of 9.5 dpc mutant embryos, but dual supplementation improved crown-rump length of mutant embryos (p 0.05; Fig. 2A ). On the other hand, somite/developmental stage was not altered by maternal diet (p > 0.05; Fig. 2B ). Weights of embryos dissected at 11.5 dpc were similar between wild-type and mutant embryos from folate or dual supplemented dams; and dual supplementation restored the reduction in embryo weight observed with iron supplementation (Fig. 2C) .
IRON SUPPLEMENTATION INCREASES THE IRON STATUS OF WILD-TYPE AND FPN1
FFE/1 DAMS
The effect of supplementation on iron status of wild-type and Fpn1 ffe/1 dams was determined. Measurements of ferritin levels in the serum of pregnant dams served as a proxy of stored iron (Fig. 3) . Maternal ferritin levels were increased with iron supplementation in both wild-type dams (1.51 6 0.45 vs. 7.85 6 1.00 lg ferritin/ml; p 0.001) and to a greater degree in Fpn1 ffe/1 dams (2.32 6 0.46 vs. 15.81 6 1.94 lg ferritin/ml; p 0.0001). This enhanced increase in ferritin was expected because the Fpn1 ffe is a model of the iron overload disorder hemochromatosis type IV (Zohn et al., 2007) . Folic acid supplementation did not alter the iron status of neither wild-type (1.51 6 0.45 vs. 0.79 6 0.27 lg ferritin/ml; p > 0.05) nor Fpn1 ffe/1 dams (2.32 6 0.46 vs. 1.81 6 0.19 lg ferritin/ ml; p > 0.05). Dual supplementation with iron and folic acid had no further effect on elevated iron status in wildtype dams (7.87 6 1.00 vs. 7.29 6 0.71 lg ferritin/ml; p > 0.05). In Fpn1 ffe/1 dams, dual supplementation reduced the iron overload observed with iron supplementation alone (7.63 6 2.41 vs. 15.81 6 1.94 lg ferritin/ml; p 0.001).
HIGH DOSE IRON SUPPLEMENTATION INFLUENCES FOLATE STATUS
To determine if folic acid supplementation increased folate status of dams, the folate content of whole maternal blood was compared between wild-type and Fpn1 ffe dams (Fig.   4A ). Folate levels were lower in blood from pregnant Fpn1 ffe/1 females than wild-type dams fed a control diet (34.99 6 1.48 vs. 42.69 6 1.55 ng folate/ml; p 0.05), indicating that Fpn1 deficiency has some impact on folate status. Folate levels increased with folic acid supplementation in both wild-type (42.69 6 1.55 vs. 50.83 6 1.82 ng folate/ml; p 0.05) and Fpn1 ffe/1 (34.99 6 1.48 vs. 47.29 6 1.95 ng folate/ml; p 0.001) dams. Surprisingly, supplementation with 0.5% carbonyl iron significantly reduced maternal folate levels in wild-type dams (42.69 6 1.55 vs. 21.60 6 2.20 ng folate/ml; p 0.0001), which was ameliorated by dual supplementation (42.69 6 1.55 vs. 37.63 6 3.75 ng folate/ml; p > 0.05). Folate levels were also reduced in Fpn1 ffe/1 dams on the high iron diet (42.69 6 1.55 vs. 26.49 6 0.95 ng folate/ml; p 0.001) and improved with dual supplementation (42.69 6 1.55 vs. 32.14 6 1.15 ng folate/ml; p 0.05).
Folate levels were also measured in embryos dissected at 11.5 dpc (Fig. 4B) . Fpn1 ffe/ffe mutant embryos showed reduced folate levels compared with wild-type littermates (35.69 6 3.17 vs. 13.17 6 2.62 ng folate/g protein; p gm protein; p 0.01), which was restored with dual supplementation with iron and folic acid in wild-type embryos. Iron supplementation slightly but not significantly reduce folate levels in Fpn1 ffe/ffe mutant embryos (13.17 6 2.62 vs. 5.63 6 3.00 ng folate/gm protein; p 5 0.12), which improved to control levels with dual supplementation (13.17 6 2.62 vs. 15.92 6 3.14 ng folate/gm protein; p > 0.05).
HIGH DOSE IRON SUPPLEMENTATION RESULTS IN MACROCYTIC ANEMIA TYPICAL OF FOLATE DEFICIENCY
Folate and iron status can affect the red blood cell (RBC) composition as measured by CBC analysis. Thus the effect of iron and folic acid supplementation on hematologic parameters was determined (Table 1 ). There was no significant difference in total RBCs, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, or RBC distribution width between wild-type or Fpn1 ffe/1 dams on the control diet or with folate supplementation. The high iron diet reduced RBC numbers and increased both the mean corpuscular volume and mean corpuscular hemoglobin in both the wild-type and Fpn1 ffe/1 dams (Table 1) . These hematological findings are consistent with the macrocytic anemia that occurs with folate deficiency. Dual supplementation with iron and folic acid reverted these changes in the wild-type, but not Fpn1 ffe/1 dams.
IRON SUPPLEMENTATION PREVENTS FOREBRAIN TRUNCATIONS IN FPN1 FFE/FFE MUTANT EMBRYOS
Our previous studies demonstrate that Fpn1 ffe/ffe mutant embryos show forebrain truncations (Mao et al., 2010) . To determine if iron, folate, or combined supplementation can rescue forebrain defects in Fpn1 ffe/ffe mutants, the size of the forebrain was measured in 9.5 dpc embryos from pregnant dams fed the various diets. Measurements were taken from the most rostral point of the eye vesicle to the most rostral point on the forebrain (Fig. 5A) . As previously demonstrated in embryos from dams fed standard mouse chow (Mao et al., 2010) , the forebrain was significantly smaller in Fpn1 ffe/ffe mutant embryos compared with wildtype littermates from dams fed the control diet (0.44 6 0.02 vs. 0.28 6 0.007 mm; p 0.0005). Interestingly, Fpn1 ffe/ffe mutant embryos without NTDs had normal sized forebrains regardless of diet (data not shown), thus all measurements were done on embryos with NTDs. The high folic acid diet had no significant effect on the reduced forebrain size of Fpn1 ffe/ffe mutants (0.44 6 0.002 vs. 0.26 6 0.01 mm; p 0.0005) but iron supplementation alone or dual supplementation restored forebrain size to wildtype levels in mutants with NTDs (0.44 6 0.02 vs. 0.38 6 0.03 mm; p > 0.05) and (0.44 6 0.02 vs. 0.32 6 0.05 mm; p > 0.05), respectively.
Discussion
Our previous studies of the Fpn1 ffe mouse line suggested that NTDs and forebrain truncations could be due to females fed control, high folic acid (10 ppm), high iron (0.5% carbonyl iron), or high folic acid and iron diets for 6 weeks. Each group represents values from 3 samples and significance was determined by to-factor ANOVA.
either iron deficiency in the embryo or iron overload in the visceral endoderm (Mao et al., 2010) . In this study, we supplemented Fpn1 ffe pregnancies with a relatively high iron diet and determined the effect on the incidence of NTDs and forebrain truncations. We predicted that iron supplementation would improve iron deficiency but also worsen iron overload in the visceral endoderm. Our data demonstrate that both NTDs and forebrain truncations are prevented by iron supplementation suggesting that these defects are likely due to iron deficiency. However, future experiments to measure iron levels in embryos and the visceral endoderm under these conditions are needed to definitively prove this assumption. Our data also suggest that NTDs in the Fpn1 ffe model are folate resistant. While the Fpn1 ffe mutant embryos have lower folate levels than wild-type littermates, folic acid supplementation did not prevent NTDs. These findings are not entirely surprising as folate deficiency alone is not sufficient to cause NTDs in the absence of additional factors (Burgoon et al., 2002; Burren et al., 2008 Burren et al., , 2010 . Thus our data indicate that NTDs in the Fpn1 mouse line are iron responsive but folate resistant.
INTERACTION OF IRON SUPPLEMENTATION AND FOLATE DEFICIENCY
Our data highlight an important interaction between high levels of iron supplementation and folate status. While supplementation with relatively high levels of iron did prevent NTDs in the Fpn1 mutant mouse line, it had negative effects on folate status in wild-type dams and embryos. Wild-type dams with high levels of iron supplementation showed signs of macrocytic anemia consistent with folate deficiency. This was further supported by improvement of anemia with the addition of folic acid supplementation. High levels of iron supplementation also resulted in reduced weight of embryo dissected at 11.5 dpc that were restored with dual supplementation. Human data support this negative interaction between high levels or iron supplementation/iron overload and folate status. For example, macrocytic anemia has been reported in individuals with the iron overload disorder hemochromatosis (see Koszewski, 1952; Granville and Dameshek, 1958; Arakawa et al., 1965; Toghill, 1965 ; for examples).
In our experiments, we used a relatively high level of iron supplementation to overcome the reduced iron transport activity of the Fpn1 transporter in the Fpn1 ffe model. While these dosages are not likely given to pregnant women, this level of supplementation is within the range of carbonyl iron dosages given in humans with severe anemia. Recommendations for iron supplementation in human populations range from 16 mg iron per day in Canada to 60 mg iron per day by the World Health Organization (Stoltzfus and Dreyfuss, 1998; Cockell et al., 2009 ). In the United States, the average multivitamin has 18 mg iron and prenatal vitamins contain 30 mg carbonyl iron. However, for severe iron deficiency anemia, dosages of 120 to 360 mg/day carbonyl iron is given (7-to 20-fold increase) and 90 to 150 mg/day (5-to 8.3-fold increase) is typically prescribed during pregnancy.
To compare with guidelines in rodents, the National Research Council recommends 35 mg/kg iron in the average rodent diet and twice this amount during pregnancy (Subcommittee on Laboratory Animal Nutrition, 1995). Thus the addition of 0.5% (500 ppm) carbonyl iron used in this study represents an approximate 15-fold increase ) and Fpn1 ffe/ffe embryos from dams fed control (yellow bar), high folic acid (10 ppm, orange bar), high iron (0.5% carbonyl iron, blue bar), or high folic acid and iron (purple bar) diets for 4 weeks before mating. Statistical significance was determined by the unpaired t test. p-values: 0.0005***, or nonsignificant (ns). The number of samples represented in each group is indicated.
over the recommended supplementation levels for rodents but is well within the range of dosages recommended for patients with severe anemia. Future studies will determine if iron supplementation with equivalent dosages used during human pregnancy would also have a similar effect on folate status of mouse dams and embryos. Iron and folate share many commonalities (Herbig and Stover, 2002) . Simultaneous deficiencies are common especially during pregnancy and result in complications including increased risk of anemia, low birth weight, premature birth, and mortality. Both iron and folate serve as cofactors for enzymatic reactions involved in a variety of metabolic processes including DNA repair and synthesis. Iron supplementation might influence folate status at multiple levels. For example, Ferritin catabolizes folate into inactive metabolites (Suh et al., 2000 (Suh et al., , 2001 . Another molecular link is the regulation of cytoplasmic serine hydroxymethyltransferase levels by iron (Oppenheim et al., , 2001 . Thus the high levels of ferritin in the serum of dams supplemented with iron could potentially cause or otherwise contribute to folate deficiency by catabolism of folate.
On the other hand, sites of iron and folate absorption and hemostasis in the mother and fetus overlap significantly and iron overload in these tissues could potentially interfere with folate absorption and/or metabolism. The primary site of both folate and iron absorption from the diet occurs in the enterocytes of the small intestine with common and distinct transporters (Lipinski et al., 2013; Visentin et al., 2014) . Once absorbed, iron and folate are delivered to the liver for storage and/or mobilization to the circulation (Gambling et al., 2011; Lipinski et al., 2013; Visentin et al., 2014) . Iron overload occurs in both intestinal enterocytes and liver macrophages with mutation of Fpn1 (Donovan et al., 2005; Zohn et al., 2007) . With the relatively high levels of iron given in this study, both sites likely are overloaded with iron potentially interfering with folate absorption and/or metabolism. Similarly, delivery of iron and folate to the embryo during neurulation depends upon the visceral endoderm of the yolk sac (Zohn and Sarkar, 2010 ) and this tissue also likely becomes overloaded in Fpn1 ffe/ffe mutant embryos with high levels of iron supplementation. This could further reduce transport of folate to the embryo.
ROLE OF FPN1 IN TRANSPORT OF OTHER METALS
Fpn1 also transports other metals and Fpn1 ffe/1 mice show reduced manganese and zinc levels (Yin et al., 2010; Madejczyk and Ballatori, 2012; Seo et al., 2016) . Deficiencies of both of these is implicated in increased NTD risk (Sever and Emanuel, 1973; Cavdar et al., 1980; Soltan and Jenkins, 1982; Buamah et al., 1984; Scott et al., 1990; Velie et al., 1999; Vats et al., 2011; Chandler et al., 2012) . However, there is an inverse relationship between iron absorption and absorption of zinc and manganese (Erikson et al., 2002 (Erikson et al., , 2004 Garcia et al., 2007) and iron supplementation competes with Fpn1-mediated transport of these and other metals O'Brien et al., 2000; Thompson et al., 2006; Hansen et al., 2009; Zhang et al., 2016) . Thus our data that iron supplementation prevents NTDs in this mouse line argue against the possibility that zinc or manganese deficiency are responsible for NTDs in this model. However, additional experiments will be necessary to definitively rule out the involvement of other metals to NTDs in the Fpn1 ffe model.
CONCLUSIONS
It is well established that iron deficiency during pregnancy results in increased risk of complications such as premature birth, reduced birth weight, and intellectual disability (Gambling et al., 2011) . Because of the increased iron requirement during pregnancy and the difficulty of replenishing stores under these conditions, it is important that sufficient iron stores are present before conception (Bothwell, 2000) . Our results presented here and in our previous studies (Mao et al., 2010; Zohn et al., 2007) make a strong case that sufficient iron stores at conception are also important for successful neural tube closure. This study provides additional support for the possibility that iron deficiency could play a role in NTDs in humans and periconception iron supplementation might prevent some folate resistant NTDs.
